Why the study?
Does the Prostar XL vascular closure device compared to ProGlide affect major vascular complication rates in patients undergoing transfemoral TAVI?
Does the Prostar XL vascular closure device compared to ProGlide affect major vascular complication rates in patients undergoing transfemoral TAVI?
ProGlide may be preferable to Prostar XL for vascular access site closure in transfemoral TAVI due to a lower rate of major vascular complications.
Answers are grounded in this paper and cite their sources.
May favor ProGlide over Prostar XL in transfemoral TAVI; leaves open need for randomized confirmation.
Prostar XL-based vascular closure in transfemoral TAVI procedures is associated with higher major vascular complication rates when compared with ProGlide; however, in-hospital mortality is similar with both devices.
No takes yet. Share an insight, caveat, or question.
Barbash et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: